MedTrace Logo

Changes in Habitual Physical Activity and Inactivity

NCT01580930 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2012-04-20

No results posted yet for this study

Summary

The purpose of this study is to determine if individuals involved in exercise training change habitual activity and inactivity behavior outside of exercise training. Eligible participants were randomly assigned to one of four groups: control, exercise training, sedentary time reduction, or exercise training plus sedentary time reduction. It was hypothesized that participants in the exercise training group will compensate for exercise training by reducing free-living physical activity behavior and increasing sedentary time. Participant free-living behavior was monitored for one week at baseline, 3, 6, 9 and 12 weeks using an activPAL wearable monitor.

Conditions

  • Habitual Physical Activity
  • Sedentary Time

Interventions

BEHAVIORAL

exercise training

12 weeks, 5 days of week, 40 min per session of exercise training

BEHAVIORAL

sedentary time reduction

participants provided with strategies to decrease sitting

BEHAVIORAL

exercsie training plus sedentary time reduction

12 weeks of exercise training (5 days a week, 40 min per session) plus given strategies for reducing sitting time

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • University of Massachusetts, Amherst

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2011-05-31
Completion
2011-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01580930 on ClinicalTrials.gov